Year archive

DSM-Firmenich AG — 2025 filings

All 67 regulatory filings released by DSM-Firmenich AG (DSFIR) in 2025, sourced directly from the official regulator.

67 Filings

2025 Period

2025 filings (67)

Filing	Released	Lang
dsm-firmenich completes €1.08 billion share repurchase program Transaction in Own Shares	2025-12-03	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-11-25	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-11-18	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-11-11	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-11-04	English
dsm-firmenich Q3 2025 trading update Investor Presentation	2025-10-30	English
dsm-firmenich Q3 2025 trading update Interim / Quarterly Report Q3 2025	2025-10-30	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-10-28	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-10-21	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-10-14	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-10-07	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-09-30	English
DSM-Firmenich AG, Halfjaarlijkse financiële verslaggeving Interim / Quarterly Report H1 2025	2025-09-23	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-09-23	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-09-16	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-09-09	English
dsm-firmenich achieves target of 100% purchased renewable electricity Regulatory Filings	2025-09-03	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-09-02	English
dsm-firmenich strengthens its Executive Committee for future growth as a consumer-focused company Board/Management Information	2025-09-01	English
dsm-firmenich strengthens its Executive Committee for future growth as a consumer-focused company Board/Management Information	2025-09-01	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-08-26	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-08-19	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-08-12	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-08-05	English
dsm-firmenich reports H1 2025 results Interim / Quarterly Report H1 2025	2025-07-31	English
dsm-firmenich reports H1 2025 results Investor Presentation	2025-07-31	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-07-29	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-07-22	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-07-15	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-07-08	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-07-01	English
dsm-firmenich announces redemption of €750 million hybrid bond Capital/Financing Update	2025-07-01	English
dsm-firmenich announces increase in share repurchase program to reduce capital to €1 billion Transaction in Own Shares	2025-06-27	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-06-24	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-06-17	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-06-10	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-06-03	English
dsm-firmenich completes sale of its stake in Feed Enzymes Alliance to Novonesis for €1.5 billion M&A Activity	2025-06-02	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-05-27	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-05-20	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-05-13	English
dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2025 Declaration of Voting Results & Voting Rights Announcements	2025-05-06	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-05-06	English
dsm-firmenich Q1 2025 trading update Earnings Release Q1 2025	2025-04-30	English
dsm-firmenich Q1 2025 trading update Investor Presentation	2025-04-30	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-04-29	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-04-22	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-04-22	English
DSM B.V. publishes 2024 Annual Report Report Publication Announcement	2025-04-16	English
DSM B.V. publishes 2024 Annual Report Report Publication Announcement	2025-04-16	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-04-15	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-04-15	English
Laetitia Pictet appointed Chief Legal, Risk and Compliance Officer of dsm-firmenich Board/Management Information	2025-04-08	English
Weekly progress on share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-04-08	English
dsm-firmenich completes shareholding increase in Andre Pectin to 90.5% M&A Activity	2025-04-03	English
dsm-firmenich announces share repurchase program to cover share plans and reduce capital Transaction in Own Shares	2025-04-01	English
dsm-firmenich showcases integrated approach to sustainability and business performance at Sustainability Investor Day AGM Information	2025-03-25	English
dsm-firmenich showcases integrated approach to sustainability and business performance at Sustainability Investor Day Environmental & Social Information	2025-03-25	English
DSM-Firmenich AG, Jaarlijkse financiële verslaggeving Annual Report (ESEF) FY 2024	2025-03-06	English
dsm-firmenich publishes 2024 Integrated Annual Report Report Publication Announcement	2025-02-28	English
dsm-firmenich publishes 2024 Integrated Annual Report Report Publication Announcement	2025-02-28	English
dsm-firmenich issues €750 million long-term bond Capital/Financing Update	2025-02-19	English
dsm-firmenich issues €750 million long-term bond Capital/Financing Update	2025-02-19	English
dsm-firmenich reports full year 2024 results Management Reports	2025-02-13	English
dsm-firmenich reports full year 2024 results Investor Presentation	2025-02-13	English
dsm-firmenich to sell stake in Feed Enzymes Alliance to its partner Novonesis for €1.5 billion M&A Activity	2025-02-11	English
dsm-firmenich to sell stake in Feed Enzymes Alliance to its partner Novonesis for €1.5 billion M&A Activity	2025-02-11	English